Bridgefront Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,702	Closed	-$263K	–	568
2023 Q2	$263K	Buy	+5,702	New	+$263K	0.14%	301
2021 Q1	–	Sell	-2,490	Closed	-$345K	–	874
2020 Q4	$345K	Buy	+2,490	New	+$345K	0.12%	325